Adiuvo Investments S.A.

Equities

ADV

PLADVIV00015

Investment Management & Fund Operators

Market Closed - Warsaw S.E. Other stock markets 11:55:41 2024-04-26 am EDT			5-day change	1st Jan Change
0.912 ^PLN	-2.98%		-2.98%	+2.47%

2023	Adiuvo Investments S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
2023	Adiuvo Investments S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI

Adiuvo Investments S.A. Reports Earnings Results for the Full Year Ended December 31, 2022

April 29, 2023 at 01:22 pm EDT

Adiuvo Investments S.A. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was PLN 0.449 million compared to PLN 1.6 million a year ago. Net loss was PLN 55.24 million compared to PLN 17.34 million a year ago.

Latest news about Adiuvo Investments S.A.

Adiuvo Investments S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 29	CI
Adiuvo Investments S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-10-02	CI
Adiuvo Investments S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-30	CI
Adiuvo Investments S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-29	CI
Adiuvo Investments S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-29	CI
Adiuvo Investments S.A. Auditor Raises 'Going Concern' Doubt	23-04-28	CI
Adiuvo Investments S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-28	CI
Adiuvo Investments S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-09-23	CI
Adiuvo Investments S.A. Auditor Raises 'Going Concern' Doubt	22-05-29	CI
Adiuvo Investments S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-23	CI
Adiuvo Investments S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	22-05-03	CI
Adiuvo Investments S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-29	CI
Adiuvo Investments S.A. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-09-30	CI
Adiuvo Investments S.A. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-24	CI
Marek Orlowski, Orenore Sp. z o.o. and Morluk Sp. z o.o. sp.k. signed a preliminary agreement to acquire additional unknown stake in Adiuvo Investments S.A. from Boguslaw Bobula, Maciej Zajac and Aleksandra Siegenthaler.	21-01-31	CI
Adiuvo Investments S.A. announced that it has received funding	19-05-16	CI
Adiuvo Investments S.A. announced that it has received PLN 4.17 million in funding	19-01-23	CI
Adiuvo Investments S.A. announced that it expects to receive PLN 4.17 million in funding	18-08-19	CI
Adiuvo Investments S.A.'s Equity Buyback announced on March 17, 2017, has expired.	18-03-15	CI
Adiuvo Investments S.A. announced that it expects to receive PLN 0.1 million in funding	17-10-26	CI
Adiuvo Investments S.A.(WSE:ADV) dropped from WIG 20 Index	17-10-20	CI
Adiuvo Investments S.A.(WSE:ADV) added to WIG 20 Index	17-10-13	CI
Adiuvo Investments S.A. announces an Equity Buyback for 2,500,000 shares, representing 21.1% for PLN 147.63 million.	17-03-17	CI
Adiuvo Investments S.A. authorizes a Buyback Plan.	17-03-16	CI
Adiuvo Float One Or Two Of Its Units On WSE	16-09-12	CI

Chart Adiuvo Investments S.A.

Duration

Period

More charts

Company Profile

Adiuvo Investments SA is a Poland-based company engaged in the financial industry. The Company focuses on the selection, development, financing and commercialization of biomedical projects on the international market. By providing intellectual property protection, technology validation in clinical trials and obtaining certificates allowing products to market, Adiuvo Investments SA is able to commercialize projects in diverse business model and internationally. The Company is looking for and invests in projects in the segments of the nutraceutical, medical devices and the digital health. Its business portfolio encompasses Airway Medix, Algae Labs, Carocelle, Cambridge Chocolate Technology, Endomedical, Esthechoc, Glia, Joint Polish Investment Fund, Marmar Investment, Nanoxide and Peptaderm.

Sector

Investment Management & Fund Operators

More about the company

Income Statement Evolution

More financial data

Sector Venture Capital

	1st Jan change	Capi.
ADIUVO INVESTMENTS S.A.	+2.47%	2.97M
UMBRA COMPANIES INC.	+31.41%	12.02B
HERCULES CAPITAL, INC.	+14.40%	3.06B
HBM HEALTHCARE INVESTMENTS AG	+2.96%	1.42B
CION INVESTMENT CORPORATION	+1.15%	616M
VERUSA HOLDING	+35.79%	577M
MOLTEN VENTURES PLC	-10.84%	579M
OCTOPUS APOLLO VCT PLC	-4.17%	492M
WOORI TECHNOLOGY INVESTMENT CO., LTD	+33.85%	488M
BRITISH SMALLER COMPANIES VCT PLC	+3.90%	304M

Venture Capital